LMAT: LeMaitre Vascular, Inc.
Performance
Watchlist
Select an item
Summary
LMAT at a glance
LMAT returned -5.57% over the past year and +9.25% a year over five years. Its worst drop in that year was -32.54%, smaller than 52% of stocks on Redstone, and its Sharpe ratio of 0.03 beats 28% of stocks on Redstone. It yields 1.17%.
Current Drawdown
-30.48%
Rolling Volatility
47.09%
Dividends
LMAT dividends
Yield
1.17%
Paid, past year
$0.95
Pays
Quarterly
Growth a year
+17.0%
Per share, by year
Yearly return over 5 years
LMAT paid $0.95 a share over the past year, every quarter. Its yearly rate rose from $0.50 in 2022 to $0.80 in 2025, 17.0% a year. With dividends reinvested it returned +9.25% a year over five years, against +8.21% on price alone.
›All 20 payments since Nov 18, 2021
- Aug 20, 2026$0.25
- May 21, 2026$0.25
- Mar 12, 2026$0.25
- Nov 20, 2025$0.20
- Aug 21, 2025$0.20
- May 15, 2025$0.20
- Mar 13, 2025$0.20
- Nov 21, 2024$0.16
- Aug 15, 2024$0.16
- May 15, 2024$0.16
- Mar 13, 2024$0.16
- Nov 15, 2023$0.14
- Aug 16, 2023$0.14
- May 16, 2023$0.14
- Mar 8, 2023$0.14
- Nov 16, 2022$0.125
- Aug 24, 2022$0.125
- May 16, 2022$0.125
- Mar 7, 2022$0.125
- Nov 18, 2021$0.11
Metrics
Risk Indicators
Profile
About LMAT
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease.
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $1.9B
- Listed
- Oct 2006
- Employees
- 655
- Headquarters
- Burlington, MA
- Website
- lemaitre.com
Comparisons